Skip to content

Effects of diabetic footwear with vibration chip and merino wool on preventing ulcer recurrence in patients with a history of diabetic foot ulceration: an open-label, randomized, controlled trial

Clinical efficacy evaluation of 3D-printed diabetic shoes and insoles on preventing foot ulceration in patients with high risk of diabetic foot or with a history of diabetic foot ulceration

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900025538
Enrollment
Unknown
Registered
2019-08-31
Start date
2019-09-01
Completion date
Unknown
Last updated
2019-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetic foot

Interventions

Experimental group:diabetic footwear with vibration chip and merino wool
control group:routine custom-made footwear

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. aged >=18 years; 2. type 1 or type 2 diabetes mellitus; 3. decrease or loss of protective foot sensation due to/as a result of diabetic peripheral neuropathy; 4. had a healed foot ulceration in the 12 months prior to/preceding randomization.

Exclusion criteria

Exclusion criteria: 1. bilateral amputation proximal to the tarsometatarsal joint; 2. the use of walking aids that offload the foot); 3. severe lower extremity artery disease(ABI<0.4,intermittent claudication or rest pain)); 4. osteoarticular diseases unrelated to T1DM or T2DM; 5. decrease or loss of vision that is difficult to treat or correct; 6. Unstable cardiovascular disease or unstable ischemic cerebrovascular disease; 7. severe renal dysfunction or severe liver dysfunction; 8. malignant tumor; 9. severe illness that would make 24-month survival unlikely (as judged by the patients physician); 10. Pregnancy or breast-feeding women; 11. Neurologic or psychiatric disease that may prevent compliance with the protocol.

Design outcomes

Primary

MeasureTime frame
ulcer recurrence rate;in-shoe plantar pressures;

Secondary

MeasureTime frame
blood flow velocity of lower extremity;transcutaneous oxygen pressure;incidence of cardiovascular events;

Countries

China

Contacts

Public ContactXingwu Ran

West China Hospital, Sichuan University

ranxingwu@163.com+86 18980601305

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 24, 2026